Bucking FDA, Peter Thiel funds “patently unethical” herpes vaccine trial - Ars Technica

Ars Technica

Bucking FDA, Peter Thiel funds “patently unethical” herpes vaccine trial Ars Technica Heavyweight tech investor and FDA-critic Peter Thiel is among conservative funders and American researchers backing an offshore herpes vaccine trial that blatantly flouts US safety regulations, according to a Monday report by Kaiser Health News. Report: Peter Thiel Is Funding a Totally Shady Offshore Herpes Vaccine TrialGizmodo Peter Thiel Helps to Fund Controversial Offshore Human Trial for Herpes VaccineSeeker Offshore vaccine tests to shortcut FDA delaysNext Big Future all 6 news articles »

from Health - Google News http://ift.tt/2wNEhUL